Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqing capsule plus adapalene gel for acne vulgaris
ChiCTR2100054470Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of yiqing in acne vulgaris (2 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoint: Acne Comprehensive Grading System Score. Started Nov 2021; status: recruiting.
02
Drugs
yiqing
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2100054470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054470.